Experimental Agents for the Treatment of Atherosclerosis: New Directions

Experimental Agents for the Treatment of Atherosclerosis: New Directions

Errika Voutyritsa,1 Georgios Kyriakos,2 Alexandros Patsouras,3 Christos Damaskos,1,4 Anna Garmpi,5 Evangelos Diamantis,6 Nikolaos Garmpis,1,7 Spyridon Savvanis8 1N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, A...

Full description

Bibliographic Details
Main Authors: Voutyritsa E, Kyriakos G, Patsouras A, Damaskos C, Garmpi A, Diamantis E, Garmpis N, Savvanis S
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:Journal of Experimental Pharmacology
Subjects:
cytokines
interleukins
losmapimod
colchicine
p-selectine
inclacumab
Online Access:https://www.dovepress.com/experimental-agents-for-the-treatment-of-atherosclerosis-new-direction-peer-reviewed-fulltext-article-JEP

Internet

https://www.dovepress.com/experimental-agents-for-the-treatment-of-atherosclerosis-new-direction-peer-reviewed-fulltext-article-JEP

Similar Items